Structure-activity relationships of G protein-coupled receptors

Archives of Medical Research

Volumn 30, Issue 6, 1999, Pages 420-435

  Ulloa Aguirre, Alfredo ^a,b   Stanislaus, Dinesh ^c   Janovick, Jo Ann ^b   Conn, P Michael ^b  

^a Hosp Gineco Obstetricia Luis C   (Mexico)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Cell surface receptors; G protein coupled receptors; G proteins

Indexed keywords

CELL SURFACE RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE;

AMINO ACID SEQUENCE; ENZYME ACTIVATION; LIGAND BINDING; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; RECEPTORS, CELL SURFACE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033401138     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-0128(99)00041-X     Document Type: Review

References (222)

1. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol. 6:1994;180.
2. Strader C.D., Fong T.M., Tota M.R., Underwood D. Structure and function of G protein-coupled receptors. Annu Rev Biochem. 63:1994;101.
3. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G-protein-coupled receptors. FASEB J. 9:1995;745.
4. Ulloa-Aguirre A., Conn P.M. G protein-coupled receptors and the G protein family. Conn P.M. Handbook of physiology-endocrinology. Section 7. Cellular endocrinology. 1998;Oxford University Press, New York. 87.p.
5. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily. conserved switch for diverse cell functions Nature. 348:1990;125.
6. Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily. conserved structure and molecular mechanism Nature. 349:1990;117.
7. Sprang S.R. G protein mechanisms. insights from structural analysis Annu Rev Biochem. 66:1997;639.
8. Dhanasekaran N., Heasley L.E., Johnson G.L. G protein-coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev. 16:1995;259.
9. van Biesen T.M., Luttrell L.M., Hawes B.E., Lefkowitz R.J. Mitogenic signaling via G protein-coupled receptors. Endocr Rev. 17:1996;698.
10. Probst W.C., Snyder L.A., Schuster D.I., Brosius J., Seaflon S.C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 11:1992;1.
11. Dohlman H.G., Thorner J., Caron M.G., Lefkowitz R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem. 60:1991;653.
12. Nathans J., Hogness D.S. Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin. Cell. 34:1983;807.
13. Pace U., Hanski E., Salomon Y., Lancet D. Odorant-sensitive adenylate cyclase may mediate olfatory reception. Nature. 316:1985;255.
14. Dixon R.A.F., Kobilka B.K., Strader D.J., Benovic J.L., Dohlman H.G., Frielle T., Bolanowsky M.A., Bennet C.D., Rands E., Diehl R.E., Mumford R.A., Slater E.E., Sigal I.S., Caron M.G., Lefkowitz R.J., Strader C.D. Cloning the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature. 321:1986;75.
15. Loosfelt H.M., Misrahi M., Atger M., Salesse R., Vu Hai-Luu Thi M.T., Jolivet A., Guiochon-Mantel A., Sar S., Jalla B., Garnier J., Milgrom E. Cloning and sequencing of porcine LH-hCG receptor cDNA. variants lacking transmembrane domain Science. 245:1989;525.
16. Kaiser U.B., Zhao D., Cardona G.R., Chin W. Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun. 189:1992;1645.
17. Karkar S.S., Musgrove L.C., Devor D.C., Sellers J.C., Neil J.D. Cloning, sequencing and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun. 189:1992;289.
18. Heckert L.L., Daley I.J., Griswold M.D. Structural organization of the follicle-stimulating hormone receptor gene. Mol Endocrinol. 6:1992;70.
19. Vassart G., Desarnaud L., Duprez L., Eggerickx D., Labbé O., Libert F., Mollerau C., Parma J., Paschke R., Tonacchera M., Vanderhaeghen P., Van Sande J., Dumont J., Parmentier M. The G protein-coupled receptor family and one of its members, the TSH receptor. Ann NY Acad Sci. 766:1995;23.
20. Ishigara T., Nakamura S., Kaziro Y., Takahashi T., Takahashi K., Nagata S. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 10:1991;1635.
21. Lin H.Y., Harris T.L., Flannery M.S., Aruffo A., Kaji E.H., Gorn A., Kolafowski L.F. Jr., Lodish H.F., Goldring S.R. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science. 254:1991;1022.
22. Ishigara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811.
23. Abou-Samra A.B., Jüppner H., Force T., Freeman M.W., Kong X.F., Schipani E., Urena P., Richards J., Bonventre J.V., Potts J.T. Jr., Kronenberg H.M., Segre G.V. Expression cloning of a parathyroid hormone/parathyroid hormone-related peptide receptor from rat osteoblast-like cells. a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium Proc Natl Acad Sci USA. 89:1992;2732.
24. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760.
25. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597.
26. 2+-sensing receptor from bovine parathyroid. Nature. 366:1993;575.
27. Kolakowski L.F. Gcrdb. a G-protein-coupled receptor database Receptors Channels. 2:1994;1.
28. Arvanitakis L., Geras-Raaka E., Gershengorn M.C. Constitutively signaling G-protein-coupled receptors and human disease. Trends Endocrinol Metab. 9:1998;27.
29. Coughlin S.R. Expanding horizons for receptors coupled to G proteins. diversity and disease Curr Opin Cell Biol. 6:1994;191.
30. Spiegel AM Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol 1995;58:143.
31. Henderson R., Baldwin J.M., Ceska T.A., Zemlin F., Beckmann E., Downing K.H. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol. 213:1990;899.
32. Unger V.M., Hargrave P.A., Baldwin J.M., Schertler G.F. Arrangement of rhodopsin transmembrane alpha-helices. Nature. 389:1997;203.
33. Baldwin J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1993;1693.
34. Ji T.H., Grossman M., Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem. 273:1998;17299.
35. Strader C.D., Sigal I.S., Register R.B., Candelore M.R., Rands E., Dixon R.A. Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci USA. 84:1987;4384.
36. 2-adrenergic receptors by sodium. J Biol Chem. 265:1992;21590.
37. 383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. J Biol Chem. 266:1991;14953.
38. Gocayne J., Robinson D.A., Fitz-Gerald M.G., Chung F.-Z., Kerlavage A.R., Lentes K.-W., Al J., Wang C.-D., Friseur C.M., Venter J.C. Primary structure of rat β-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequencing analysis. further evidence for a multigene family Proc Natl Acad Sci USA. 84:1987;8296.
39. Fraser C.M., Wong C.-D., Robinson D.A., Gocayne J.D., Venter J.C. Site directed mutagenesis of m1 muscarinic acetylcholine receptors. conserved aspartic acids play important roles in receptor function Mol Pharmacol. 36:1990;840.
40. Strader C.D., Sigal I.S., Dixon R.A.F. Genetic approaches to the determination of structure-function relationships of G protein-coupled receptors. Trends Pharmacol Sci. Suppl.)Dec:1989;26.
41. Sealfon S.C., Weinstein H., Millar R.P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev. 18:1997;180.
42. Heding A., Vrecl M., Bogerd J., McGregor A., Sellar R., Taylor P.L., Eidne K.A. Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics. J Biol Chem. 273:1998;11472.
43. Lin X., Janovick J.A., Brothers S., Blömenrohr M., Bogerd J., Conn P.M. Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation. Mol Endocrinol. 12:1998;161.
44. 1-adrenoceptor-dependent adenylate cyclase from purified components. EMBO J. 5:1986;1509.
45. Benovic J.L., Bouvier M., Caron M.G., Lefkowitz R.J. Regulation of adenylyl cyclase-coupled β-adrenergic receptors. Annu Rev Cell Biol. 4:1988;405.
46. Schramm M., Selinger Z. Message transmission. receptor controlled adenylate cyclase system Science. 225:1984;1350.
47. Tang W.-J., Gilman A.G. Adenylyl cyclases. Cell. 70:1992;869.
48. Fung B.K.-K., Stryer L. Photolyzed rhodopsin catalyzes the exchange of GTP for bound GDP in retinal rod outer segments. Proc Natl Acad Sci USA. 77:1980;2500.
49. Stryer L. Visual excitation and recovery. J Biol Chem. 266:1991;10711.
50. Khorana H.G. Rhodopsin, photoreceptor of the rod cell. An emerging pattern for structure and function. J Biol Chem. 267:1982;1.
51. Rarick H.M., Artemyev N.O., Hamm H.E. A site on Rod G protein α subunit that mediates effector activation. Science. 256:1992;1031.
52. Noel J.P., Hamm H.E., Sigler P.B. The 2.2 Å crystal structure of transducin-α complexed with GTPγs. Nature. 366:1993;654.
53. Lambright D.G., Sondek J., Bohm A., Skiba N.P., Hamm H.E., Sigler P.B. The 2.0 Å crystal structure of a heterotrimeric G protein. Nature. 379:1996;311.
54. Wheeler G.L., Bitensky M.W. A light-activated GTPase in vertebrate photoreceptors. regulation of light-activated cyclic GMP phosphodiesterase Proc Natl Acad Sci USA. 74:1977;4238.
55. 2+ in vertebrate photoreceptor excitation and adaptation. Annu Rev Physiol. 54:1992;153.
56. Dixon R.A., Sigal L.S., Candelore M.R., Register R.B., Rands E., Strader C.D. Structural features required for ligand binding to the β-adrenergic receptor. EMBO J. 6:1987;3269.
57. 2-adrenergic receptor. Biochemistry. 29:1990;2335.
58. Ji I., Murdoch W.J., Ji T.H. Activation of membrane receptors. Endocrinology. 3:1995;187.
59. Bouvier M., Loisel T.P., Hébert T.H. Dynamic regulation of G-protein coupled receptor palmitoylation. potential role in receptor function Biochem Soc Trans. 23:1995;577.
60. 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem 1989;264:7564.
61. van Koppen C.J., Nathanson N.M. The cysteine residue in the carboxy-terminal domain of the m2 muscarinic acetylcholine receptor is not required for receptor-mediated inhibition of adenylate cyclase. J Neurochem. 57:1991;1873.
62. 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. J Biol Chem. 268:1993;8003.
63. Zhu O., Wang A., Ascoli M. The lutropin/choriogonadotropin receptor is palmitoylated at intracellular cysteine residues. Mol Endocrinol. 9:1995;141.
64. Birdsall N.J.M., Cohen F., Lazareno S., Matsui H. Allosteric regulation of G-protein-linked receptors. Biochem Soc Trans. 23:1993;108.
65. George S.T., Ruoho A.E., Malbon C.C. N-glycosylation in expression and function of β-adrenergic receptors. J Biol Chem. 261:1986;16559.
66. Ji I., Slaughter R.G., Ji T.H. N-linked oligosaccharides are not required for hormone binding of the lutropin receptor in a Leydig tumor cell line and rat granulosa cells. Endocrinology. 127:1990;494.
67. Liu X.B., Davis D., Segaloff D.L. Disruption of potential sites for N-linked glycosylation does not impair hormone binding to the lutropin/choriogonadotropin receptors if Asn-173 is left intact. J Biol Chem. 268:1993;1513.
68. Davidson J.S., Flanagan C.A., Zhou W., Becker I.I., Elario R., Emeran W., Seaflon S.C., Millar R.P. Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor. role in receptor expression but not ligand binding Mol Cell Endocrinol. 107:1995;241.
69. Ray K., Clapp P., Goldsmith P.K., Spiegel A.M. Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. J Biol Chem. 273:1998;34558.
70. Davidson J.S., Flanagan C.A., Davies P.D., Hapgood J., Myburgh D., Elario R., Millar R.P., Forrest-Owen W., McArdle C.A. Incorporation of an additional glycosylation site enhances expression of functional human gonadotropin-releasing hormone receptor. Endocr Rev. 4:1996;207.
71. Davis D., Liu X., Segaloff D.L. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol. 9:1995;159.
72. Rozell T.G., Wang H., Liu X., Segaloff D.L. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not the lutropin/choriogonadotropin receptor. Mol Endocrinol. 9:1995;1727.
73. Davis D.P., Rozell T.G., Liu X., Segaloff D.L. The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction. Mol Endocrinol. 11:1997;550.
74. Fong T.M., Anderson S.A., Yu H., Huang R.-R.C., Strader C.D. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol. 41:1991;24.
75. De la Peña P., Delgado L.M., Del Camino D., Barros F. Two isoforms of the thyrotropin-releasing hormone receptor generated by alternative splicing have indistinguishable functional properties. J Biol Chem. 267:1992;25703.
76. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakisuka A., Ito S., Ichikawa S., Narumiya S. Splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 365:1993;155.
77. o. J Biol Chem. 268:1993;26067.
78. Negishi M., Sugimoto Y., Arie A., Narumiya S., Ichikawa A. Two isoforms of prostaglandin E receptor EP3 subtype. Different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J Biol Chem. 268:1993;9517.
79. Takeuchi K., Takahashi N., Abe T., Abe K. Two isoforms of the rat kidney EP3 receptor derived by alternative RNA splicing. intrarenal expression co-localization Biochem Biophys Res Commun. 199:1994;834.
80. 1C-adrenoceptor splice variants. FEBS Lett. 363:1995;256.
81. Simoni M., Gromoll J., Höppner W., Kamischke A., Krafft T., Stähle D., Nieschlag E. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men. identification and characterization of two discrete FSH receptor isoforms J Clin Endocrinol Metabol. 84:1999;751.
82. Khan H., Yarney T.A., Sairam M.R. Cloning of alternately spliced mRNA transcripts coding for variants of ovine testicular follitropin receptor lacking the G protein coupling domains. Biochem Biophys Res Commun. 190:1993;888.
83. Sairam M.R., Jiang L.G., Yarney T.A., Khan H. Follitropin signal transduction. alternative splicing of the FSH receptor gene produces a dominant negative form of the receptor which inhibits hormone action Biochem Biophys Res Commun. 226:1996;717.
84. Sairam M.R., Jiang L.G., Yarney T.A., Khan H. Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor. implications for pleiotropic actions of the hormone Mol Reprod Dev. 48:1997;471.
85. Yarney T.A., Jiang L., Khan H., MacDonald E.A., Laird D.W., Sairam M.R. Molecular cloning, structure, and expression of a testicular follitropin receptor with selective alteration in the carboxy terminus that affects signaling function. Mol Reprod Dev. 48:1997;458.
86. Harazono A., Sugimoto Y., Ichikawa A., Negishi M. Enhancement of adenylate cyclase stimulation by prostaglandin E receptor EP3 subtype isoforms with different efficiencies. Biochem Biophys Res Commun. 201:1994;340.
87. Takahashi K., Tsuchida K., Tanabe Y., Masu M., Nakanishi S. Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination. J Biol Chem. 268:1993;19341.
88. Chattopadhyay N., Mithal A., Brown E.M. The calcium-sensing receptor. a window into the physiology and pathophysiology of mineral ion metabolism Endocr Rev. 17:1996;289.
89. Dixon R.A., Sigal I.S., Rands E., Register R.B., Candelore M.R., Blake A.D., Strader C.D. Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core. Nature. 326:1987;73.
90. Wong S.K.-F., Slaughter C., Ruoho A.E., Ross E.M. The catecholamine binding site of the β-adrenergic receptor is formed by juxtaposed membrane-spanning domains. J Biol Chem. 263:1988;7925.
91. Zhukovsky E.A., Oprian D.D. Effect of carboxylic acid side chains on the absorption maximum of visual pigments. Science. 246:1989;928.
92. 3-adrenergic receptor. Mol Pharmacol. 48:1995;492.
93. Strader C.D., Candelore M.R., Hill W.S., Sigal I.S., Dixon R.A. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J Biol Chem. 264:1989;13572.
94. Gether U., Kobilka B.K. G protein-coupled receptors. II. Mechanism of agonist activation. J Biol Chem. 273:1998;17979.
95. Fong T.M., Yu H., Huang R.R.C., Strader C.D. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. Biochemistry. 31:1992;11806.
96. Huang R.R., Yu H., Strader C.D., Fong T.M. Localization of the ligand binding site of the neurokinin-1 receptor. interpretation of chimeric mutations and single-residue substitutions Mol Pharmacol. 45:1994;690.
97. Trumpp-Kallmeyer S., Chini B., Mouillac B., Barberis C., Hoflack J., Hibert M. Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors. Pharm Acta Helv. 70:1995;255.
98. Huang R.R., Vicario P.P., Strader C.D., Fong T.M. Identification of residues involved in ligand binding to the neurokinin-2 receptor. Biochemistry. 34:1995;10048.
99. Fong T.M., Huang R.R., Yu H., Strader C.D. Mapping the ligand binding site of the NK-1 receptor. Regul Pept. 46:1993;43.
100. Ykota Y., Akazawa C., Ohkubo H., Nakanishi S. Delineation of structural domains involved in the subtype specificity of the tachykinin receptors through chimeric formation of substance P/substance K receptors. EMBO J. 11:1992;3585.
101. Colson A.-O., Perlman J.H., Smolyar A., Gershengorn M.C., Osman R. Static and dynamic roles of extracellular loops in G-protein-coupled receptors. a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor Biophys J. 74:1998;1087.
102. Wadsworth H.L., Chazenbalk G.D., Nagayama Y., Russo D., Rapoport B. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science. 249:1990;1423.
103. Liu L.-W., Vu T.-K.H., Esmon C.T., Coughlin S.R. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem. 266:1991;16977.
104. LaRosa G.J., Thomas K.M., Kaufmann M.E., Mark R., White M., Taylor L., Gray G., Witt D., Navarro J. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem. 267:1992;25402.
105. DeMartino J.A., Riper G.V., Siciliano S.J., Molineaux C.J., Konteatis Z.D., Rosen H., Springer M.S. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J Biol Chem. 269:1994;14446.
106. Jüppner H., Schipani E., Bringhurst F.R., McClure I., Keutmann H.T., Potts J.T., Kronenberg H.M., Abou-Samra A.B., Segre G.V., Gardella T.J. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH- (1-34). Endocrinology. 134:1994;879.
107. Segaloff D.L., Ascoli M. The lutropin/choriogonadotropin receptor ... 4 years later. Endocr Rev. 14:1993;324.
108. Simoni M., Gromoll J., Nieschlag E. The follicle-stimulating hormone receptor. biochemistry, molecular biology, physiology, pathophysiology Endocr Rev. 18:1997;739.
109. Ulloa-Aguirre A., Timossi C. Structure-function relationship of follicle-stimulating hormone and its receptor. Hum Reprod Update. 4:1998;260.
110. Misrahi M., Thu Vu Hai M., Ghinea N., Loosfelt H., Meduri G., Atger M., Jolivet A., Gross B., Savouret J.-F., Dessen P., Milgrom E. Molecular and cellular biology of gonadotropin receptors. Adashi E.Y., Leung C.K. The Ovary. 1993;Raven Press, New York. 57.p.
111. Bhowmick N., Huang J., Puett D., Isaacs N.W., Lapthorn A.J. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/choriogonadotropin receptor by site-directed mutagenesis and modeling. Mol Endocrinol. 10:1996;1147.
112. Moyle W.R., Bernard M.P., Myers R.V., Marko O.M., Strader C.D. Lutropin/β-adrenergic receptor chimeras bind choriogonadotropin and adrenergic ligands but are not expressed at the cell surface. J Biol Chem. 266:1991;10807.
113. Ryu K, Lee H, Kim S, Beauchamp J, Tung C-S, Isaacs NW, Ji I, Ji TH. Modulation of high affinity hormone binding. Human choriogonadotropin binding to the exodomain of the receptor is influenced by exoloop 2 of the receptor. J Biol Chem 1998;273:6285.
114. Ryu K., Gilchrist R.L., Tung C.-S., Ji I., Ji T.H. High affinity hormone binding to the extracellular N-terminal exodomain of the follicle-stimulating hormone receptor is critically modulated by exoloop 3. J Biol Chem. 273:1998;28953.
115. Ji I., Ji T.H. Differential roles of exoloop 1 of the human follicle-stimulating hormone receptor in hormone binding and receptor activation. J Biol Chem. 270:1995;15970.
116. Gilchrist R.L., Ryu K.-S., Ji I., Ji T.H. The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J Biol Chem. 217:1996;19283.
117. 583 in the third extracellular loop of the lutropin/choriogonadotropin receptor is critical for signaling. J Biol Chem. 217:1996;925.
118. Gerszten R.E., Chen J., Ishii M., Ishii K., Wang L., Nanevicz T., Turck C.W., Vu T.-K.H., Coughlin S.R. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature. 368:1994;648.
119. Simon M.I., Strathmann P., Gautam N. Diversity of G proteins in signal transduction. Science. 252:1991;802.
120. Hepler J.R., Gilman A.G. G Proteins. Trends Pharmacol Sci. 17:1992;383.
121. Neer E.J. Heterotrimeric G proteins. organizers of transmembrane signals Cell. 80:1995;249.
122. Kjeldgaard M., Nyborg J., Clark B.F.C. The GTP binding motif. variations on a theme FASEB J. 10:1996;1347.
123. iα1 and the mechanism of GTP hydrolysis. Science. 265:1994;1405.
124. Tang W.-J., Gilman A.G. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science. 254:1991;1500.
125. i-protein βγ subunits. Nature. 356:1992;159.
126. Taussig R., Quarmby L.M., Gilman A.G. Regulation of purified type-I and type-II adenylyl cyclases by G protein βγ subunits. J Biol Chem. 268:1993;9.
127. Blank J.L., Brattain K.A., Exton J.H. Activation of cytosolic phosphoinositide phospholipase C by G-protein βγ subunits. J Biol Chem. 267:1992;23069.
128. Boyer J.L., Waldo G.L., Harden T.K. βγ-subunit activation of G-protein-regulated phospholipase C. J Biol Chem. 267:1992;25451.
129. Jelsema C.L., Axelrod J. Stimulation of phospholipase A2 activity in bovine rod outer segments by the βγ subunits of transducin and its inhibition by the α subunit. Proc Natl Acad Sci USA. 84:1987;3623.
130. + channel via phospholipase A2. Nature. 337:1989;557.
131. + channel in heart. Nature. 325:1987;321.
132. Bokoch G.M. Interplay between Ras-related and heterotrimeric GTP binding proteins. lifestyles of the BIG and little FASEB J. 10:1996;1290.
133. 12 class of G proteins. Cell Signal. 8:1996;235.
134. Lin H.C., Duncan J.A., Kozasa T. Gilman AG. Sequestration of the G protein βγ subunit complex inhibits receptor-mediated endocytosis. Proc Natl Acad Sci USA. 95:1998;5057.
135. Parker E.M., Kameyama K., Higashijima T., Ross E.M. Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem. 266:1991;519.
136. Smrcka A.V., Helper J.R., Brown K.O., Sternweiss P.C. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science. 251:1991;804.
137. q/11, and phospholipase Cβ1. J Biol Chem. 267:1992;8081.
138. i-family G-proteins. studies with pertussis toxin-resistant G-protein mutants Biochem J. 321:1997;721.
139. 1A receptor. J Biol Chem. 264:1989;14848.
140. Peroutka S.J. 5-Hydroxytryptamine receptors. J Neurochem. 60:1993;408.
141. sα Biochemistry. 32:1993;11064.
142. o-like G proteins. J Biol Chem. 269:1994;12954.
143. Pin J.P., Duvoisin R. The metabotropic glutamate receptors. structure and functions Neuropharmacology. 34:1995;1.
144. Zheng F., Gallagher J.P. 1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced burst firing is mediated by native pertussis toxin-sensitive metabotropic receptor at rat dorsolateral septal nucleus neurons. Neuroscience. 68:1995;423.
145. 16 contribute to the specificity of activation by the C5A receptor. Mol Pharmacol. 47:1995;218.
146. 2 cascades in CHO cells expressing the human cDNA of the TSH receptor. Mol Cell Endocrinol. 74:1990;R1.
147. Kosugi S., Okajima F., Ban T., Hidaka A., Shenker A., Kohn L.D. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not the cAMP signal induced by TSH and receptor antibodies. J Biol Chem. 267:1992;24153.
148. 3 cells. evidence from palmitoylation and overexpression of G proteins Biol Reprod. 59:1998;579.
149. Stanislaus D., Pinter J.H., Janovick J.A., Conn P.M. Mechanisms mediating multiple physiological responses to gonadotropin-repeating hormone. Mol Cell Endocrinol. 144:1998;1.
150. Kurtenbach E., Curtis C.A.M., Pedder E.K., Aitken A., Harris A.C.M., Hulme E.C. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J Biol Chem. 265:1990;13702.
151. Wess J., Bonner T.I., Dörje F., Brann M.R. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol Pharmacol. 38:1990;517.
152. Cotecchia S., Ostrowski J., Kjelsberg M.A., Caron M.G., Lefkowitz R.J. Discrete amino acid sequences of the α1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem. 267:1992;1633.
153. Lameh J., Philip M., Sharma Y.K., Moro O., Ramachandran J., Sadee W. Hm1 muscarinic cholinergic receptor internalization requires a domain in the third cytoplasmic loop. J Biol Chem. 267:1992;13406.
154. Hawes B.E., Luttrell L.M., Exum S.T., Lefkowitz R.J. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J Biol Chem. 269:1994;15776.
155. Strader C.D., Dixon R.A., Cheung A.H., Candelore M.R., Blake A.D., Sigal I.S. Mutations that uncouple the β-adrenergic receptor from Gs and increase agonist affinity. J Biol Chem. 262:1987;16439.
156. 2-adrenergic receptor. J Biol Chem. 263:1988;15985.
157. 2-adrenergic receptors. delineation of domains involved in effector coupling and ligand binding specificity Science. 249:1988;1310.
158. s. J Biol Chem. 266:1991;4816.
159. o by Mastoparan, related amphiphilic peptides and hydrophobic amines. J Biol Chem. 265:1990;14176.
160. Wess J. Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci. 14:1993;308.
161. Arora K.K., Sakai A., Catt K.J. Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor. J Biol Chem. 270:1995;22820.
162. 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem. 267:1992;8342.
163. 2 receptor second intracellular loop. Eur J Pharmacol. 267:1994;185.
164. Konig B., Arendt A., McDowell Kahlert M., Hargrave P.A., Hofmann K.P. Three cytoplasmic loops of rhodopsin interact with transducin. Proc Natl Acad Sci USA. 86:1989;6878.
165. Franke R.R., Sakmar T.P., Graham R.M., Khorana H.G. Structure and function of rhodopsin. Studies of the interaction between rhodopsin cytoplasmic domain and transducin. J Biol Chem. 267:1992;14757.
166. Ohyama K., Yamano Y., Chaki S., Kondo T., Inagami T. Domains for G-protein coupling in angiotensin II receptor type I. studies by site-directed mutagenesis Biochem Biophys Res Commun. 189:1992;677.
167. Damaj B.B., McColl S.R., Neote K., Songqing N., Ogborn K.T., Hébert C.A., Naccache P.H. Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J. 10:1996;1426.
168. 2A-adrenergic receptors. J Biol Chem. 269:1994;31915.
169. Nussenzveig D.R., Thaw C.N., Gershengorn M.C. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. J Biol Chem. 269:1994;28123.
170. Arora K.K., Krsmanovic L.Z., Mores N., O'Farrell H., Catt K.J. Mediation of cyclic AMP signaling by the first intracellular loop of the gonadotropin-releasing hormone receptor. J Biol Chem. 273:1998;25581.
171. Mitchell R., McCulloch D., Lutz E., Johnson M., MacKenzie C., Fennell M., Fink G., Zhou W., Seaflon S.C. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature. 392:1998;411.
172. Samama P., Cotecchia S., Costa T., Lefkowitz R.J. A mutation-induced
173. Leff P. The two-state model of receptor activation. Trends Pharmacol Sci. 16:1995;89.
174. De Lean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem. 255:1980;7108.
175. Ballesteros J., Kitanovic S., Guarnieri F., Davies P., Fromme B.J., Konvicka K., Chi L., Millar R.P., Davidson J.S., Weinstein H., Seaflon S.C. Functional microdomains in G-protein-coupled receptors. The conserved arginine-CAGE motif in the gonadotropin-releasing hormone receptor. J Biol Chem. 273:1998;10445.
176. Lefkowitz R.J. Turned on to ill effect. Nature. 365:1993;603.
177. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci. 14:1993;303.
178. Robinson R., Cohen G.B., Zhukovsky E.A., Oprian D.D. Constitutively active mutants of rhodopsin. Neuron. 9:1992;719.
179. Kudo M., Osuga Y., Kobilka B.K., Hsueh A.J. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J Biol Chem. 271:1996;22470.
180. Schulz A., Schöneberg T., Paschke R., Schultz G., Guderman T. Role of the third intracellular loop for the activation of gonadotropin receptors. Mol Endocrinol. 13:1999;181.
181. 1B-adrenergic receptor by all amino acid substitutions at a single site. J Biol Chem. 267:1992;1430.
182. 2-adrenergic receptor. J Biol Chem. 268:1993;16483.
183. Gether U., Ballesteros J.A., Seifert R., Sanders-Bush E., Weinstein H., Kobilka B.K. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem. 272:1997;2587.
184. Milligan G., Bond R.A., Lee M. Inverse agonism. pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci. 16:1995;10.
185. Wilden U., Kuhn H. Light-dependent phosphorylation of rhodopsin. number of phosphorylation sites Biochemistry. 21:1982;3014.
186. Thompson P., Findlay J.B.C. Phosphorylation of ovine rhodopsin. Biochem J. 220:1984;773.
187. 2+-dependent interaction of recoverin with rhodopsin. J Biol Chem. 270:1995;18060.
188. Freedman N.J., Lefkowitz R.J. Desensitization of G protein-coupled receptors. Recent Prog Horm Res. 51:1996;319.
189. Krupnick J.G., Benovic L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 38:1998;289.
190. Clark R.B., Friedman J., Dixon R.A., Strader C.D. Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol. 36:1989;343.
191. Lefkowitz R.J. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem. 273:1998;18677.
192. Sterne-Marr R., Benovic J.L. Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam Horm. 51:1995;193.
193. 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem. 267:1992;3530.
194. Krueger K.M., Daaka Y., Pitcher J.A., Lefkowitz R.J. The role of sequestration in G protein-coupled receptor resensitization. J Biol Chem. 272:1997;5.
195. Penela P., Ruiz-Gómez A., Castaño J.G., Mayot F. Jr. Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway. J Biol Chem. 273:1998;35238.
196. Jinnah HA, Conn PM. GnRH-stimulated LH release from rat anterior pituitary cells in culture: refractoriness and recovery. Am J Physiol 1985;249(Endocrinol Metab 12):E619.
197. Mahan L.C., Koachman A.M., Insel P.A. Genetic analysis of β-adrenergic receptor internalization and down-regulation. Proc Natl Acad Sci USA. 82:1985;129.
198. McArdle C.A., Gorospe W.C., Huckle W.R., Conn P.M. Homologous down-regulation of gonadotropin-releasing hormone receptors and desensitization of gonadotropes. lack of dependence on protein kinase C Mol Endocrinol. 1:1987;420.
199. Hadcock J.R., Malbon C.C. Down-regulation of β-adrenergic receptors. agonist-induced reduction in receptor mRNA levels Proc Natl Acad Sci USA. 85(8):1978;5021.
200. Hausdorff W.P., Caron M.G., Lefkowitz R.J. Turning off the signal. desensitization of β-adrenergic receptor function FASEB J. 4:1990;2881.
201. 2+ levels. Mol Pharmacol. 25:1984;51.
202. Jennes L., Stumpf W.E., Conn P.M. Receptor-mediated binding and uptake of GnRH agonist and antagonist by pituitary cells. Peptides. 5(Suppl 1):1984;215.
203. Lin X., Janovick J.A., Conn P.M. Mutations at the consensus phosphorylation sites in the third intracellular loop of the rat gonadotropin-releasing hormone receptor. effects on receptor ligand binding and signal transduction Biol Reprod. 59:1998;1470.
204. Vrecl M., Andreson L., Hanyalogly A., McGregor A.M., Groarke A.D., Milligan G., Taylor P.L., Eidne K.A. Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor. effect of β-arrestin on internalization kinetics Mol Endocrinol. 12:1998;1818.
205. Wang Z., Liu X., Ascoli M. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone. Mol Endocrinol. 11:1997;183.
206. 2-adrenergic receptor facilitate sequestration. Biochemistry. 35:1996;4155.
207. Cornea A., Janovich J.A., Lin X., Conn P.M. Simultaneous and independent visualization of the GnRH receptor and its ligand. evidence for independent processing and recycling in living cells Endocrinology. 140:1994;4272.
208. Berman D.M., Gilman A.G. Mammalian RGS proteins. barbarians at the gate J Biol Chem. 273:1998;1269.
209. Neill J.D., Duck L.W., Sellers J.C., Musgrove L.C., Scheschonka A., Druey K.M., Kherl J.H. Potential role for a regulator of G protein signaling (RGS2) in gonadotropin releasing hormone (GnRH) stimulated desensitization. Endocrinology. 138:1997;843.
210. 2+ mobilization. J Biol Chem. 271:1996;23711.
211. Kaupmann K., Burns C., Hoyer D., Seuwen K., Lübbert H. Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett. 331:1993;53.
212. McArdle C.A., Countis R. GnRH and PACAP action in gonadotropes. Cross-talk between phosphoinositidase C and adenylyl cyclase mediated signaling pathways. Trends Endocrinol Metab. 7:1996;168.
213. Denhardt D.T. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell. the potential for multiplex signalling Biochem J. 318:1996;729.
214. Luttrell L.M., Della Rocca J., van Biesen T., Lutterll D.K., Lefkowitz R.J. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. J Biol Chem. 272:1997;4637.
215. Maggio R., Vogel Z., Wess J. Co-expression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular 'cross-talk' between G-protein-linked receptors. Proc Natl Acad Sci USA. 90:1993;3103.
216. Monnot C., Bihoreau C., Conchon S., Curnow K.M., Corvol P., Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem. 271:1996;1507.
217. Osuga Y., Hayashi M., Kudo M., Conti M., Kobilka B., Hsueh A.J.W. Co-expression of defective luteinizing hormone receptor fragments reconstitutes ligand-induced signal generation. J Biol Chem. 272:1997;25006.
218. Govardhan C.P., Oprian D.D. Active site-directed inactivation of constitutively active mutants of rhodopsin. J Biol Chem. 269:1994;6524.
219. q/11. Cell Signal. 10:1998;101.
220. 3 cells Endocrinology. 139:1998;2472.
221. Rockman H.A., Chien K.R., Choi D.-J., Iaccarino G., Hunter J.J., Ross J., Lefkowitz R.J., Koch W.J. Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA. 95:1998;7000.
222. Sα-selective G protein antagonists. Proc Natl Acad Sci USA. 95:1998;346.